261 related articles for article (PubMed ID: 21872563)
1. Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity.
Mizuno T; Doi Y; Mizoguchi H; Jin S; Noda M; Sonobe Y; Takeuchi H; Suzumura A
Am J Pathol; 2011 Oct; 179(4):2016-27. PubMed ID: 21872563
[TBL] [Abstract][Full Text] [Related]
2. Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid {beta} neurotoxicity in in vitro and in vivo models of Alzheimer's disease.
Doi Y; Mizuno T; Maki Y; Jin S; Mizoguchi H; Ikeyama M; Doi M; Michikawa M; Takeuchi H; Suzumura A
Am J Pathol; 2009 Nov; 175(5):2121-32. PubMed ID: 19834064
[TBL] [Abstract][Full Text] [Related]
3. TGF-β induced by interleukin-34-stimulated microglia regulates microglial proliferation and attenuates oligomeric amyloid β neurotoxicity.
Ma D; Doi Y; Jin S; Li E; Sonobe Y; Takeuchi H; Mizuno T; Suzumura A
Neurosci Lett; 2012 Oct; 529(1):86-91. PubMed ID: 22985514
[TBL] [Abstract][Full Text] [Related]
4. Reduced mitochondria membrane potential and lysosomal acidification are associated with decreased oligomeric Aβ degradation induced by hyperglycemia: A study of mixed glia cultures.
Huang YC; Hsu SM; Shie FS; Shiao YJ; Chao LJ; Chen HW; Yao HH; Chien MA; Lin CC; Tsay HJ
PLoS One; 2022; 17(1):e0260966. PubMed ID: 35073330
[TBL] [Abstract][Full Text] [Related]
5. PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer's disease.
Wang BR; Shi JQ; Ge NN; Ou Z; Tian YY; Jiang T; Zhou JS; Xu J; Zhang YD
J Neuroinflammation; 2018 May; 15(1):132. PubMed ID: 29720213
[TBL] [Abstract][Full Text] [Related]
6. Androgen alleviates neurotoxicity of β-amyloid peptide (Aβ) by promoting microglial clearance of Aβ and inhibiting microglial inflammatory response to Aβ.
Yao PL; Zhuo S; Mei H; Chen XF; Li N; Zhu TF; Chen ST; Wang JM; Hou RX; Le YY
CNS Neurosci Ther; 2017 Nov; 23(11):855-865. PubMed ID: 28941188
[TBL] [Abstract][Full Text] [Related]
7. Oligomeric amyloid β induces IL-1β processing via production of ROS: implication in Alzheimer's disease.
Parajuli B; Sonobe Y; Horiuchi H; Takeuchi H; Mizuno T; Suzumura A
Cell Death Dis; 2013 Dec; 4(12):e975. PubMed ID: 24357806
[TBL] [Abstract][Full Text] [Related]
8. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
[TBL] [Abstract][Full Text] [Related]
9. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.
Magga J; Puli L; Pihlaja R; Kanninen K; Neulamaa S; Malm T; Härtig W; Grosche J; Goldsteins G; Tanila H; Koistinaho J; Koistinaho M
J Neuroinflammation; 2010 Dec; 7():90. PubMed ID: 21138577
[TBL] [Abstract][Full Text] [Related]
10. The neuroprotective effects of milk fat globule-EGF factor 8 against oligomeric amyloid β toxicity.
Li E; Noda M; Doi Y; Parajuli B; Kawanokuchi J; Sonobe Y; Takeuchi H; Mizuno T; Suzumura A
J Neuroinflammation; 2012 Jun; 9():148. PubMed ID: 22742657
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-colony stimulating factor attenuates oligomeric amyloid β neurotoxicity by activation of neprilysin.
Doi Y; Takeuchi H; Mizoguchi H; Fukumoto K; Horiuchi H; Jin S; Kawanokuchi J; Parajuli B; Sonobe Y; Mizuno T; Suzumura A
PLoS One; 2014; 9(7):e103458. PubMed ID: 25062013
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate attenuates amyloid β-induced inflammation and neurotoxicity in EOC 13.31 microglia.
Cheng-Chung Wei J; Huang HC; Chen WJ; Huang CN; Peng CH; Lin CL
Eur J Pharmacol; 2016 Jan; 770():16-24. PubMed ID: 26643169
[TBL] [Abstract][Full Text] [Related]
13. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
Hickman SE; Allison EK; El Khoury J
J Neurosci; 2008 Aug; 28(33):8354-60. PubMed ID: 18701698
[TBL] [Abstract][Full Text] [Related]
14. Mechanism mediating oligomeric Aβ clearance by naïve primary microglia.
Yang CN; Shiao YJ; Shie FS; Guo BS; Chen PH; Cho CY; Chen YJ; Huang FL; Tsay HJ
Neurobiol Dis; 2011 Jun; 42(3):221-30. PubMed ID: 21220023
[TBL] [Abstract][Full Text] [Related]
15. Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid-beta oligomers.
Gandy S; Simon AJ; Steele JW; Lublin AL; Lah JJ; Walker LC; Levey AI; Krafft GA; Levy E; Checler F; Glabe C; Bilker WB; Abel T; Schmeidler J; Ehrlich ME
Ann Neurol; 2010 Aug; 68(2):220-30. PubMed ID: 20641005
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
17. Deferoxamine enhances alternative activation of microglia and inhibits amyloid beta deposits in APP/PS1 mice.
Zhang Y; He ML
Brain Res; 2017 Dec; 1677():86-92. PubMed ID: 28963052
[TBL] [Abstract][Full Text] [Related]
18. Reversal of
Wickstead ES; Karim HA; Manuel RE; Biggs CS; Getting SJ; McArthur S
Oxid Med Cell Longev; 2020; 2020():2139192. PubMed ID: 32617132
[TBL] [Abstract][Full Text] [Related]
19. Pseudoginsenoside-F11 alleviates oligomeric β-amyloid-induced endosome-lysosome defects in microglia.
Yao XC; Xue X; Zhang HT; Zhu MM; Yang XW; Wu CF; Yang JY
Traffic; 2019 Jan; 20(1):61-70. PubMed ID: 30375163
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of Chunghyuldan from amyloid beta oligomer induced neuroinflammation in vitro and in vivo.
Kim HG; Kim JY; Whang WW; Oh MS
Can J Physiol Pharmacol; 2014 Jun; 92(6):429-37. PubMed ID: 24820962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
